Cited by 234Liver Disease Diagnosis and TreatmentAdipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and Obesity

The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.

Irisin is inversely associated with intrahepatic triglyceride contents in obese adults

Zhang, Hui-Jie, Zhang, Xian-Feng, Ma, Zhi-Min, Pan, Ling-Ling, Chen, Zheng, Han, Hai-Wei, Han, Cheng-Kun, Zhuang, Xiong-Jie, Lu, Yan, Li, Xue-Jun, Yang, Shu-Yu, Li, Xiao-Ying·2013·Journal of Hepatology

DOI 10.1016/j.jhep.2013.04.030

Open this paper in CoChat — free account

Abstract

Background & aims Obesity is closely related to non-alcoholic fatty liver disease (NAFLD), which has become an important public health problem because of its high prevalence and association with metabolic syndromes. Irisin was recently identified as a novel peptide to improve obesity and glucose homeostasis, and considered to be therapeutic for human metabolic diseases. The aim of this study was to examine the association of serum irisin concentration and liver triglyceride contents in obese Chinese adults.Methods Serum irisin levels were measured and liver fat contents determined by (1)H MRS in 296 obese adults. Anthropometric parameters and blood biochemical indexes including liver enzymes, glucose, and lipid profiles were detected. The liver triglyceride contents of subjects were measured by (1)H MRS. The protein levels of irisin were determined by quantitative ELISA.Results We found that serum irisin levels were reduced in obese adults with NAFLD. By dividing the distribution of intrahepatic triglyceride (IHTG) contents into quartiles, serum irisin levels were reduced gradually with the increase of IHTG contents (p<0.01). Higher serum irisin levels were associated with preferable TG levels. Serum ALT and AST concentrations were inversely correlated with serum irisin levels. Multivariate linear regression analysis demonstrated that serum irisin levels were independently associated with liver fat (p<0.01). By logistic regression analysis, the odds ratio for higher IHTG contents was reduced by 12.4% per 1 SD increase in serum irisin concentrations after adjustment for multivariate metabolic factors [OR (95% CI); 0.876 (0.777-0.987)].Conclusions These results demonstrated that serum irisin concentrations were inversely associated with the triglyceride contents in the liver and liver enzymes in obese Chinese adults.

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2013.04.030

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
Szczepaniak, L. S., Nurenberg, P., Leonard, D. S., Browning, J. D., Reingold, J. S., Grundy, S. M., Hobbs, H. H., & Dobbins, R. L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,573
Hepatic Fibroblast Growth Factor 21 Is Regulated by PPARα and Is a Key Mediator of Hepatic Lipid Metabolism in Ketotic States
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice
Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151
FNDC5 and Irisin in Humans: I. Predictors of Circulating Concentrations in Serum and Plasma and II. mRNA Expression and Circulating Concentrations in Response to Weight Loss and Exercise
Huh, J. Y., Panagiotou, G., Mougios, V., Brinkoetter, M., Vamvini, M. T., Schneider, B. E., & Mantzoros, C. S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.09.002 · Cited by 1,040
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
Ellingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T., Eppler, E., Bouzakri, K., Wueest, S., Muller, Y. D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2513 · Cited by 922
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Tiniakos, D. G., Vos, M. B., & Brunt, E. M. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102132 · Cited by 870
Role of Myokines in Exercise and Metabolism
Pedersen, B. K., Åkerström, T. C. A., Nielsen, A. R., & Fischer, C. P. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00080.2007 · Cited by 841
The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation
Barbatelli, G., Murano, I., Madsen, L., Hao, Q., Jimenez, M., Kristiansen, K., Giacobino, J., Matteis, R. D., & Cinti, S. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00600.2009 · Cited by 788
Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss
Johnson, N. A., Sachinwalla, T., Walton, D. W., Smith, K., Armstrong, A., Thompson, M. W., & George, J. (2009) · Hepatology · doi:10.1002/hep.23129 · Cited by 631

Flagged first, then by citations

Show all 34 references

1 of the 34 references couldn’t be matched to a known paper.

Sorted by citations

Physiology and role of irisin in glucose homeostasis
Perakakis, N., Triantafyllou, G. A., Fernández-Real, J. M., Huh, J. Y., Park, K. H., Seufert, J., & Mantzoros, C. S. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.221 · Cited by 621
Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes
Liu, T., Shi, C., Gao, R., Sun, H., Xiong, X., Ding, L., Chen, Q., Li, Y., Wang, J., Kang, Y., et al. (2015) · Clinical Science · doi:10.1042/cs20150009 · Cited by 378
Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008–2011)
Lee, Y., Jung, K. S., Kim, S. U., Yoon, H.-J., Yun, Y., Lee, B., Kang, E. S., Han, K., Lee, H. C., & Soo, B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.051 · Cited by 340
A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese
Xia, M., Chen, Y., Lin, H., Ma, H., Li, X., Aleteng, Q., Li, Q., Wang, D., Hu, Y., Pan, B., et al. (2016) · Scientific Reports · doi:10.1038/srep38214 · Cited by 300
Hepatic Selective Insulin Resistance at the Intersection of Insulin Signaling and Metabolic Dysfunction-Associated Steatotic Liver Disease
Bo, T., Gao, L., Yao, Z., Shao, S., Wang, X., Proud, C. G., & Zhao, J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.006 · Cited by 293
The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review
Gonzalez-Gil, A. M., & Elizondo-Montemayor, L. (2020) · Nutrients · doi:10.3390/nu12061899 · Cited by 278
Irisin in metabolic diseases
Polyzos, S. A., Anastasilakis, A. D., Efstathiadou, Z. A., Makras, P., Perakakis, N., Kountouras, J., & Mantzoros, C. S. (2018) · Endocrine · doi:10.1007/s12020-017-1476-1 · Cited by 262
Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis
Bhanji, R. A., Narayanan, P., Allen, A. M., Malhi, H., & Watt, K. D. S. (2017) · Hepatology · doi:10.1002/hep.29420 · Cited by 259
Three new players in energy regulation: Preptin, adropin and irisin
Aydın, S. (2014) · Peptides · doi:10.1016/j.peptides.2014.03.021 · Cited by 261
FNDC5 overexpression and irisin ameliorate glucose/lipid metabolic derangements and enhance lipolysis in obesity
Xiong, X.-Q., Chen, D., Sun, H.-J., Ding, L., Wang, J.-J., Chen, Q., Li, Y.-H., Zhou, Y.-B., Han, Y., Zhang, F., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.06.017 · Cited by 242
Irisin, a Novel Myokine, Regulates Glucose Uptake in Skeletal Muscle Cells via AMPK
Lee, H. J., Lee, J. O., Kim, N., Kim, J. K., Kim, H. I., Lee, Y. W., Kim, S. J., Choi, J., Oh, Y., Kim, J. H., et al. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1353 · Cited by 224
Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
Lim, S. K., Kim, J., & Targher, G. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.04.008 · Cited by 224
Irisin in patients with nonalcoholic fatty liver disease
Polyzos, S. A., Kountouras, J., Anastasilakis, A. D., Geladari, E. V., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2013.09.013 · Cited by 215
Nonalcoholic fatty liver disease: Evolving paradigms
Lonardo, A., Nascimbeni, F., Maurantonio, M., Marrazzo, A., Rinaldi, L., & Adinolfi, L. E. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i36.6571 · Cited by 204
Circulating Irisin in Healthy, Young Individuals: Day-Night Rhythm, Effects of Food Intake and Exercise, and Associations With Gender, Physical Activity, Diet, and Body Composition
Anastasilakis, A. D., Pοlyzos, S. A., Saridakis, Z. G., Kynigopoulos, G., Skouvaklidou, E. C., Molyvas, D., Vasiloglou, M. F., Apostolou, A., Karagiozoglou‐Lampoudi, Τ., Siopi, A., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1367 · Cited by 190
Irisin protects against sepsis-associated encephalopathy by suppressing ferroptosis via activation of the Nrf2/GPX4 signal axis
Wang, J., Zhu, Q., Wang, Y., Peng, J., Shao, L., & Li, X. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.05.023 · Cited by 185
Impact of Skeletal Muscle Mass on Metabolic Health
Kim, G., & Kim, J. H. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.35.1.1 · Cited by 183
Role of irisin in physiology and pathology
Liu, S., Cui, F., Ning, K., Wang, Z., Fu, P., Wang, D., & Xu, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.962968 · Cited by 186
Pathophysiology of Non Alcoholic Fatty Liver Disease
Petta, S., Gastaldelli, A., Rebelos, E., Bugianesi, E., Messa, P., Miele, L., Svegliati‐Baroni, G., Valenti, L. V. C., & Bonino, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122082 · Cited by 182
Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease
Boutari, C., Perakakis, N., & Mantzoros, C. S. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.1.33 · Cited by 172
New role of irisin in hepatocytes: the protective effect of hepatic steatosis in vitro
Park, M.-J., Kim, D.-I., Choi, J.-H., Heo, Y.-R., & Park, S.-H. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.04.010 · Cited by 168
Irisin ameliorates age‐associated sarcopenia and metabolic dysfunction
Guo, M., Yao, J., Li, J., Zhang, J., Wang, D., Zuo, H., Zhang, Y., Xu, B., Zhong, Y., Shen, F., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13141 · Cited by 172
Irisin as a muscle-derived hormone stimulating thermogenesis – A critical update
Hofmann, T., Elbelt, U., & Stengel, A. (2014) · Peptides · doi:10.1016/j.peptides.2014.01.016 · Cited by 162
Association of Serum Irisin with Metabolic Syndrome in Obese Chinese Adults
Yan, B., Shi, X., Zhang, H., Pan, L., Ma, Z., Liu, S., Liu, Y., Li, X., Yang, S., & Li, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094235 · Cited by 165
Longitudinal variation of circulating irisin after an energy restriction‐induced weight loss and following weight regain in obese men and women
Crujeiras, A. B., Pardo, M., Roca-Rivada, A., Navas‐Carretero, S., Zulet, M. Á., Martínez, J. A., & Casanueva, F. F. (2013) · American Journal of Human Biology · doi:10.1002/ajhb.22493 · Cited by 156
Irisin Inhibits Hepatic Cholesterol Synthesis via AMPK-SREBP2 Signaling
Tang, H. W., Yu, R., Liu, S., Huwatibieke, B., Li, Z., & Zhang, W. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.02.041 · Cited by 152
Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients
Crujeiras, A. B., Zulet, M. Á., Lopez‐Legarrea, P., de la Iglesia, R., Pardo, M., Carreira, M. C., Martínez, J. A., & Casanueva, F. F. (2013) · Metabolism · doi:10.1016/j.metabol.2013.12.007 · Cited by 149
Herbal medicines and nonalcoholic fatty liver disease
Yao, H., Qiao, Y.-J., Ya-li, Z., Tao, X., Xu, L., Yin, L., Qi, Y., & Peng, J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6890 · Cited by 141
Involvement of GPX4 in irisin's protection against ischemia reperfusion‐induced acute kidney injury
Zhang, J., Bi, J., Ren, Y., Du, Z., Li, T., Wang, T., Zhang, L., Wang, M., Wei, S., Lv, Y., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29903 · Cited by 135
FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice
Liu, T., Xiong, X., Ren, X., Zhao, M., Shi, C., Wang, J., Zhou, Y., Zhang, F., Han, Y., Gao, X.-Y., et al. (2016) · Diabetes · doi:10.2337/db16-0356 · Cited by 135
Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα
Lü, Y., Liu, X., Jiao, Y., Xiong, X., Wang, E., Wang, X., Zhang, Z., Zhang, H., Pan, L., Guan, Y., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74438 · Cited by 132
Chronic Exercise Training and Circulating Irisin in Adults: A Meta-Analysis
Qiu, S., Cai, X., Sun, Z., Schumann, U., Zügel, M., & Steinacker, J. M. (2015) · Sports Medicine · doi:10.1007/s40279-014-0293-4 · Cited by 129
Browning of white fat: does irisin play a role in humans?
Elsen, M., Raschke, S., & Eckel, J. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0189 · Cited by 130
Sarcopenia and fatty liver disease
Kim, J. A., & Choi, K. M. (2019) · Hepatology International · doi:10.1007/s12072-019-09996-7 · Cited by 125
Irisin: a new molecular marker and target in metabolic disorder
Chen, J., Huang, Y., Gusdon, A. M., & Qu, S. (2015) · Lipids in Health and Disease · doi:10.1186/1476-511x-14-2 · Cited by 126
Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway
Han, F., Zhang, S., Hou, N., Wang, D., & Sun, X. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00443.2015 · Cited by 122
The Role of Sirt6 in Obesity and Diabetes
Kuang, J., Chen, L., Tang, Q., Zhang, J., Li, Y., & He, J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00135 · Cited by 122
Irisin, Two Years Later
Novelle, M. G., Contreras, C., Romero, A., López, M., & Diéguez, C. (2013) · International Journal of Endocrinology · doi:10.1155/2013/746281 · Cited by 122
The Roles of Xenobiotic Receptors: Beyond Chemical Disposition
Mackowiak, B., Hodge, J., Stern, S., & Wang, H. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.081042 · Cited by 123
The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis
Wu, Y., Zheng, Q., Zou, B., Yeo, Y. H., Li, X., Li, J., Xie, X., Feng, Y., Stave, C. D., Zhu, Q., et al. (2020) · Hepatology International · doi:10.1007/s12072-020-10023-3 · Cited by 109
Decreased saliva/serum irisin concentrations in the acute myocardial infarction promising for being a new candidate biomarker for diagnosis of this pathology
Aydın, S., Aydın, S., Kobat, M. A., Kalaycı, M. Z., Eren, M. N., Yılmaz, M., Kuloğlu, T., Gül, E., Seçen, Ö., Alataş, Ö. D., et al. (2014) · Peptides · doi:10.1016/j.peptides.2014.04.002 · Cited by 106
Irisin: ‘fat’ or artefact
Crujeiras, A. B., Pardo, M., & Casanueva, F. F. (2014) · Clinical Endocrinology · doi:10.1111/cen.12627 · Cited by 104
Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges
Kuchay, M. S., Martínez‐Montoro, J. I., Choudhary, N. S., Fernández‐García, J. C., & Ramos‐Molina, B. (2021) · Biomedicines · doi:10.3390/biomedicines9101346 · Cited by 105
Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy
Xiang, L., Xiang, G., Yue, L., Zhang, J., & Zhao, L. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.04.036 · Cited by 98
Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
Lim, S. K., Taskinen, M., & Borén, J. (2018) · Obesity Reviews · doi:10.1111/obr.12820 · Cited by 99
Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease
Gan, D., Wang, L., Jia, M., Ru, Y., Ma, Y., Zheng, W., Zhao, X., Yang, F., Wang, T., Mu, Y., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.04.023 · Cited by 100
Association of circulating neuregulin 4 with metabolic syndrome in obese adults: a cross-sectional study
Cai, C., Lin, M., Xu, Y., Li, X., Yang, S., & Zhang, H. (2016) · BMC Medicine · doi:10.1186/s12916-016-0703-6 · Cited by 93
Exercise hormone irisin mitigates endothelial barrier dysfunction and microvascular leakage–related diseases
Bi, J., Zhang, J., Ren, Y., Du, Z., Zhang, Y., Liu, C., Wang, Y., Zhang, L., Shi, Z., Wu, Z., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.136277 · Cited by 89
Irisin Is Regulated by CAR in Liver and Is a Mediator of Hepatic Glucose and Lipid Metabolism
Mo, L., Shen, J., Liu, Q., Zhang, Y., Kuang, J., Pu, S., Cheng, S., Zou, M., Jiang, W., Jiang, C., et al. (2016) · Molecular Endocrinology · doi:10.1210/me.2015-1292 · Cited by 89
Irisin, a Link among Fatty Liver Disease, Physical Inactivity and Insulin Resistance
Arias, M., Ranchal, I., Romero‐Gómez, M., & Crespo, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151223163 · Cited by 87
Irisin stimulates cell proliferation and invasion by targeting the PI3K/AKT pathway in human hepatocellular carcinoma
Shi, G., Tang, N., Qiu, J., Zhang, D., Huang, F., Cheng, Y., Ding, K., Li, W., Zhang, P., & Tan, X. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.148 · Cited by 87
Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery
Ebert, T., Stepan, H., Schrey-Petersen, S., Kralisch, S., Hindricks, J., Hopf, L., Platz, M., Lössner, U., Jeßnitzer, B., Drewlo, S., et al. (2013) · Cytokine · doi:10.1016/j.cyto.2013.11.009 · Cited by 86
The relationship between circulating irisin levels and endothelial function in lean and obese subjects
Hou, N., Han, F., & Sun, X. (2014) · Clinical Endocrinology · doi:10.1111/cen.12658 · Cited by 86
Circulating Irisin Concentrations Are Associated with a Favourable Lipid Profile in the General Population
Oelmann, S., Nauck, M., Völzke, H., Bahls, M., & Friedrich, N. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154319 · Cited by 83
Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk
Kuchay, M. S., Martínez‐Montoro, J. I., Kaur, P., Fernández‐García, J. C., & Ramos‐Molina, B. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101696 · Cited by 86
A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3′UTR
Metwally, M., Bayoumi, A., Romero‐Gómez, M., Thabet, K., John, M., Adams, L. A., Huo, X., Aller, R., García‐Monzón, C., Arias, M., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.021 · Cited by 81
Interaction between sarcopenia and nonalcoholic fatty liver disease
Joo, S. K., & Kim, W. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0358 · Cited by 78
Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study
Lee, M. J., Kim, E., Bae, S.-J., Kim, G., Park, S. W., Choe, J., Jung, C. H., Lee, W. J., & Kim, H. (2018) · Gut and Liver · doi:10.5009/gnl18070 · Cited by 78
Irisin in humans: recent advances and questions for future research
Boström, P., Fernández‐Real, J. M., & Mantzoros, C. S. (2013) · Metabolism · doi:10.1016/j.metabol.2013.11.009 · Cited by 79
The “irisin system”: From biological roles to pharmacological and nutraceutical perspectives
Flori, L., Testai, L., & Calderone, V. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118954 · Cited by 81
Irisin: A New Code Uncover the Relationship of Skeletal Muscle and Cardiovascular Health During Exercise
Ma, C., Ding, H., Deng, Y., Liu, H., Xiong, X., & Yang, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.620608 · Cited by 76
Postconditioning with Irisin Attenuates Lung Ischemia/Reperfusion Injury by Suppressing Ferroptosis via Induction of the Nrf2/HO‐1 Signal Axis
Wang, Y., Dong, Z., Zhang, Z., Wang, Y., Yang, K., & Li, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9911167 · Cited by 75
Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease
Altajar, S., & Baffy, G. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00065 · Cited by 79
Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis
Wijarnpreecha, K., Panjawatanan, P., Thongprayoon, C., Jaruvongvanich, V., & Ungprasert, P. (2018) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_237_17 · Cited by 72
Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects
Lopez-Legarrea, P., de la Iglesia, R., Crujeiras, A. B., Pardo, M., Casanueva, F. F., Zulet, M. A., & Martinez, J. A. (2014) · Nutrition & Diabetes · doi:10.1038/nutd.2014.7 · Cited by 60
Circulating irisin and glucose metabolism in overweight/obese women: effects of α-lipoic acid and eicosapentaenoic acid
Huerta, A. E., Prieto-Hontoria, P. L., Fernández‐Galilea, M., Sáinź, N., Cuervo, M., Martínez, J. A., & Moreno-Aliaga, M. J. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0400-5 · Cited by 70
Myostatin signals through miR-34a to regulate Fndc5 expression and browning of white adipocytes
Ge, X., Sathiakumar, D., Lua, B.-N., Kukreti, H., Lee, M., & McFarlane, C. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.110 · Cited by 67
Distinctive Roles of Sirtuins on Diabetes, Protective or Detrimental?
Song, J., Yang, B., Jia, X., Li, M., Tan, W. F., Ma, S., Shi, X., & Feng, L. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00724 · Cited by 67
Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients
de la Iglesia, R., Lopez‐Legarrea, P., Crujeiras, A. B., Pardo, M., Casanueva, F. F., Zulet, M. Á., & Martínez, J. A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12383 · Cited by 66
Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis
Filip, R., Radzki, R., & Bieńko, M. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s170533 · Cited by 60
Effects and Molecular Mechanism of GST-Irisin on Lipolysis and Autocrine Function in 3T3-L1 Adipocytes
Gao, S., Li, F., Li, H., Yi, H., Liu, Y., & Chen, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147480 · Cited by 63
Combined training, FNDC5/irisin levels and metabolic markers in obese men: A randomised controlled trial
Bonfante, I. L. P., Chacon‐Mikahil, M. P. T., Brunelli, D. T., Gáspari, A. F., Duft, R. G., Lopes, W. A., Bonganha, V., Libardi, C. A., & Cavaglieri, C. R. (2017) · European Journal of Sport Science · doi:10.1080/17461391.2017.1296025 · Cited by 60
Irisin, a newly discovered myokine, is a novel biomarker associated with physical activity in patients with chronic obstructive pulmonary disease
Ijiri, N., Kanazawa, H., Asai, K., Watanabe, T., & Hirata, K. (2015) · Respirology · doi:10.1111/resp.12513 · Cited by 60
Association between Serum Irisin Levels and Non-Alcoholic Fatty Liver Disease in Health Screen Examinees
Choi, E. S., Kim, M. K., Song, M. K., Kim, J., Kim, E. S., Chung, W. J., Park, K. S., Cho, K. B., Hwang, J. S., & Jang, B. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110680 · Cited by 58
Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial
Daneshi‐Maskooni, M., Keshavarz, S. A., Qorbani, M., Mansouri, S., Alavian, S. M., Badri-Fariman, M., Jazayeri-Tehrani, S. A., & Sotoudeh, G. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2465-0 · Cited by 57
Hepatic estrogen receptor α improves hepatosteatosis through upregulation of small heterodimer partner
Wang, X., Lu, Y., Wang, E., Zhang, Z., Xiong, X., Zhang, H., Lu, J., Zheng, S., Yang, J., Xia, X., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.029 · Cited by 59
Lower circulating irisin is associated with nonalcoholic fatty liver disease and type 2 diabetes
Shanaki, M., Moradi, N., Emamgholipour, S., Fadaei, R., & Poustchi, H. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.03.037 · Cited by 57
Lack of Adipocyte-Fndc5/Irisin Expression and Secretion Reduces Thermogenesis and Enhances Adipogenesis
Pérez-Sotelo, D., Roca-Rivada, A., de la Torre, I. B., Baltar, J., Castro, A. I., Domínguez, E., Collado, M., Casanueva, F. F., & Pardo, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-16602-z · Cited by 59
Irisin promotes cardiac progenitor cell-induced myocardial repair and functional improvement in infarcted heart
Zhao, Y., Wang, J., Yano, N., Zhang, L. X., Wang, H., Zhang, S.-Y., Qin, G., Dubielecka, P., Zhuang, S., Liu, P., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27037 · Cited by 57
Non‐alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey
Moon, J. H., Koo, B. K., & Kim, W. K. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12719 · Cited by 57
An update on the validity of irisin assays and the link between irisin and hepatic metabolism
Pοlyzos, S. A., & Mantzoros, C. S. (2015) · Metabolism · doi:10.1016/j.metabol.2015.06.005 · Cited by 55
Serum Irisin and Oxytocin Levels as Predictors of Metabolic Parameters in Obese Children
Binay, Ç., Paketçi, C., Güzel, S., & Samancı, N. (2017) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.3963 · Cited by 59
Common single nucleotide polymorphisms in the FNDC5 gene are associated with glucose metabolism but do not affect serum irisin levels in Japanese men with low fitness levels
Tanisawa, K., Taniguchi, H., Sun, X., Ito, T., Cao, Z., Sakamoto, S., & Higuchi, M. (2014) · Metabolism · doi:10.1016/j.metabol.2014.01.005 · Cited by 51
Fibronectin Type III Domain–Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Petta, S., Valenti, L. V. C., Svegliati‐Baroni, G., Ruscica, M., Pipitone, R. M., Dongiovanni, P., Rychlicki, C., Ferri, N., Cammà, C., Fracanzani, A. L., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00056 · Cited by 50
Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes
Liu, J., Hu, Y., Zhang, H., Xu, Y., & Wang, G. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.07.020 · Cited by 52
The relationships of irisin with bone mineral density and body composition in PCOS patients
Gao, S., Cheng, Y., Zhao, L., Chen, Y., & Liu, Y. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2767 · Cited by 48
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
Ballestri, S., Nascimbeni, F., Romagnoli, D., Baldelli, E., Targher, G., & Lonardo, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030355 · Cited by 48
Metabolic cross-talk between skeletal muscle and adipose tissue in high-intensity interval training vs. moderate-intensity continuous training by regulation of PGC-1α
Shirvani, H., & Arabzadeh, E. (2018) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-018-0491-4 · Cited by 47
Update on genetics and epigenetics in metabolic associated fatty liver disease
Zhu, X., Xia, M., & Gao, X. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221132138 · Cited by 50
Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle
Poggiogalle, E., Donini, L. M., Lenzi, A., Chiesa, C., & Pacifico, L. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i10.1747 · Cited by 47
Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise
Verdú, E., Homs, J., & Boadas‐Vaello, P. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182413333 · Cited by 57
Circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus — correlation with pancreatic β-cell function
Yang, M., Chen, P., Jin, H., Xie, X., Gao, T., Yang, L., & Yu, X. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-133 · Cited by 46
CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPARα expression
Yang, Z. H., Li, P., Shang, Q., Wang, Y. A., He, J., Ge, S., Jia, R., & Fan, X. (2020) · Science Advances · doi:10.1126/sciadv.abc5022 · Cited by 45
Locus Characterization and Gene Expression of Bovine FNDC5: Is the Myokine Irisin Relevant in Cattle?
Komolka, K., Albrecht, E., Schering, L., Brenmoehl, J., Hoeflich, A., & Maak, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088060 · Cited by 44
Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty Liver
Canivet, C. M., Bonnafous, S., Rousseau, D., Leclère, P. S., Lacas‐Gervais, S., Patouraux, S., Sans, A., Luci, C., Bailly‐Maitre, B., Iannelli, A., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165705 · Cited by 45
Novel Roles of Follistatin/Myostatin in Transforming Growth Factor-β Signaling and Adipose Browning: Potential for Therapeutic Intervention in Obesity Related Metabolic Disorders
Pervin, S., Reddy, S. T., & Singh, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.653179 · Cited by 42
Impact of exercise on muscle and nonmuscle organs
Boström, P., Graham, E. L., Georgiadi, A., & Ma, X. (2013) · IUBMB Life · doi:10.1002/iub.1209 · Cited by 50
Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses
Li, Z., Lin, M., Liu, C., Wang, D., Shi, X., Zheng, C., Liu, Y., Yang, S., & Li, X. (2018) · Cytokine · doi:10.1016/j.cyto.2018.03.023 · Cited by 45
Irisin-encoding gene (FNDC5) variant is associated with changes in blood pressure and lipid profile in type 2 diabetic women but not in men
Brondani, L. D. A., Boelter, G., Assmann, T. S., Leitão, C. B., Canani, L. H. S., & Crispim, D. (2015) · Metabolism · doi:10.1016/j.metabol.2015.05.005 · Cited by 41
Association of serum irisin and body composition with chronic kidney disease in obese Chinese adults: a cross-sectional study
Yang, S., Xiao, F., Pan, L., Zhang, H., Ma, Z., Liu, S., Liu, Y., Zhang, W., Zeng, X. Y., Liu, C., et al. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0009-5 · Cited by 41

Authors: Zhang, H.-J., Zhang, X.-F., Ma, Z.-M., Pan, L.-L., Chen, Z., Han, H.-W., Han, C.-K., Zhuang, X.-J., Lu, Y., Li, X.-J., Yang, S.-Y., & Li, X.-Y.
Affiliations: Xiamen University (CN)
Shanghai Jiao Tong University (CN)
Corresponding author: Li, Xiao-Ying
ORCID: Chen, Zheng
Venue: Journal of Hepatology
Publisher: Elsevier BV
Published: 2013-09
Volume: 59
Issue: 3
Pages: 557-562
ISSN: 0168-8278 (ISSN-L)
DOI: 10.1016/j.jhep.2013.04.030
OpenAlex: W2101439943
Cited by: 234
References: 34
Citations by year: 2026: 7 · 2025: 11 · 2024: 15 · 2023: 7 · 2022: 29 · 2021: 13 · 2020: 22 · 2019: 11 · 2018: 21 · 2017: 21 · 2016: 22 · 2015: 26 · 2014: 18 · 2013: 11
FWCI: 18.70
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Hepatology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords: irisin, intrahepatic triglyceride, non-alcoholic fatty liver disease, obesity, hepatic steatosis, liver fat, alanine aminotransferase, aspartate aminotransferase, serum biomarkers, Chinese adults
MeSH terms: Adult, Aged, Alanine Transaminase, Aspartate Aminotransferases, China, Cross-Sectional Studies, Fatty Liver, Female, Fibronectins, Humans, Liver, Male, Middle Aged, Magnetic Resonance Spectroscopy, Obesity, Triglycerides, Asian People, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Irisin is inversely associated with intrahepatic triglyceride contents in obese adults

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks